Valuation: DexCom, Inc.

Market Cap 28.06B 488B 24.54B 22.63B 20.81B 39.42B 2,700B 40.1B 270B 106B 1,320B 105B 103B 4,549B P/E 2026 *
29.7x
P/E 2027 * 24.9x
Enterprise Value 27.64B 481B 24.16B 22.29B 20.49B 38.82B 2,659B 39.49B 266B 104B 1,300B 104B 102B 4,480B EV / Sales 2026 *
5.29x
EV / Sales 2027 * 4.6x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 day-2.86%
1 week+3.61%
Current month+4.13%
1 month+4.13%
3 months+6.89%
6 months+7.30%
Current year+6.60%
1 week 1,284
Extreme 1284
1,331.04
1 month 1,245
Extreme 1245
1,331.04
Current year 1,064.65
Extreme 1064.65
1,331.04
1 year 1,062.55
Extreme 1062.55
1,581
3 years 1,062.55
Extreme 1062.55
2,318.97
5 years 1,062.55
Extreme 1062.55
3,366.38
10 years 212.78
Extreme 212.775
3,366.38
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
-2.86%+3.61% - - 28.06B
+0.35%-6.21%-32.11%-17.29% 155B
+1.48%-1.88%-9.81%-8.19% 103B
-1.89%-4.20%+0.65%+54.93% 57.7B
-1.11%+1.09%+37.83%+53.63% 52.27B
+2.81%+2.87%-13.14%-40.29% 42.68B
+2.02%-2.13% - - 33.35B
+0.38%+1.50%+62.41%-6.78% 25.36B
-0.79%+4.40%-3.52%-18.16% 21.03B
+1.31%+0.94%-7.59%-7.69% 20.61B
Average +0.47%+0.53%+4.34%+1.27% 56.83B
Weighted average by Cap. +1.26%-1.60%-6.69%+0.02%

Financials

2026 *2027 *
Net sales 5.22B 90.83B 4.57B 4.21B 3.87B 7.34B 503B 7.46B 50.3B 19.74B 246B 19.62B 19.19B 847B 5.83B 101B 5.09B 4.7B 4.32B 8.19B 561B 8.33B 56.1B 22.01B 274B 21.88B 21.4B 945B
Net income 959M 16.68B 839M 774M 711M 1.35B 92.32B 1.37B 9.24B 3.62B 45.12B 3.6B 3.52B 156B 1.16B 20.12B 1.01B 933M 858M 1.63B 111B 1.65B 11.14B 4.37B 54.43B 4.35B 4.25B 188B
Net Debt -429M -7.45B -375M -346M -318M -602M -41.25B -613M -4.13B -1.62B -20.16B -1.61B -1.57B -69.5B -1.28B -22.27B -1.12B -1.03B -949M -1.8B -123B -1.83B -12.33B -4.84B -60.23B -4.81B -4.7B -208B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
14/07/26 MX$1,293.00 -2.86% 3,400
13/07/26 MX$1,331.04 +6.91% 8,050
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
72.73USD
Average target price
85.46USD
Spread / Average Target
+17.50%

Quarterly revenue - Rate of surprise